Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Normal skin results from interactions between EGF and the Tabby mutation.

The tumescent technique improves hair micrografting by providing lasting anesthesia, reducing bleeding, and increasing patient comfort.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Tremella fuciformis Berk helps protect hair growth from stress effects.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

A pathway helps maintain long telomeres in both stem and cancer cells.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

TURP specimens should be checked for various tumors, not just common prostate issues.

Hair-thread Tourniquet Syndrome, where hair or thread tightly wraps around a body part, is not rare and requires early detection to prevent serious damage.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tofacitinib taken by mouth helps treat hair loss in children.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

Children with partial biotinidase deficiency are healthy at birth but may develop symptoms that improve with biotin therapy.

Oral tofacitinib successfully treated total body hair loss in one patient.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

Thioglycolate compounds in brow lamination can cause skin irritation and other health issues.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A rare scalp tumor was removed from a 49-year-old woman, with a good outlook if benign but needing careful monitoring if malignant.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Modified β-catenin causes different effects in hair and skin cells, leading to cysts or tumors.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

These temporary hair dyes may be harmful to human health.